Related Experiment Videos
Genetic alterations in breast cancer
1Laboratoire d'Oncogénétique, Centre René Huguenin, St.-Cloud, France.
Genes, Chromosomes & Cancer
|December 1, 1995
Summary
Genetic alterations drive breast cancer development. Key mutations include protooncogene amplifications, TP53 mutations, and tumor suppressor gene losses, aiding clinical oncology through genetic markers.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Breast cancer etiology is complex, involving genetic alterations.
- Numerous studies focus on identifying frequent mutations in breast tumorigenesis.
Purpose of the Study:
- To identify and characterize genetic abnormalities in breast tumors.
- To map breast cancer susceptibility genes using linkage analysis.
Main Methods:
- Analysis of genetic alterations in breast tumors.
- Linkage analyses in families with hereditary breast cancer.
Main Results:
- Common abnormalities include protooncogene amplifications (MYC, ERBB2), 11q13 DNA amplification, TP53 mutations, and loss of heterozygosity on multiple chromosomes.
- Tumor suppressor gene inactivation is suggested by loss of heterozygosity.
- Mapping of breast cancer susceptibility genes like TP53, BRCA1, and BRCA2.
Conclusions:
- Genetic alterations are central to breast cancer etiology.
- Identified genetic markers can be applied in clinical oncology for diagnosis and risk assessment.